Pulmuone Corporate (017810) Stock Price & Analysis

017810 Stock Chart & Stats

$8,040.00-$80.00(-0.99%)

At close: Oct 30 3:30 PM GMT+9

Day’s Range: $8,000.00 - $8,610.00
52-Week Range: $8,000.00 - $14,120.00
Previous Close: $8,120.00
Volume: N/A
Average Volume (3M): 13.36K
Market Cap: KRW 296.62B
Enterprise Value: KRW 1.94T
Total Cash (Recent Filing): KRW 164.54B
Total Debt (Recent Filing): KRW 1.40T
Price to Earnings (P/E): 10.3
Beta: -0.03
Next Earnings: Nov 18, 2026 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Mar 31, 2026
Dividend Yield: 1.27%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Revenue expanded steadily from 2021 through TTM, showing durable top-line momentum. Continued growth in packaged and prepared foods can support scale, broaden distribution economics, and provide a base for earnings improvement over the next several quarters.

Earnings Recovery

TTM net income is materially higher than 2025, following the 2022 loss, while operating profit margins are modest but improving. This recovery indicates better earnings capacity, although the business remains below its strongest margin profile.

Improving Cash Generation

Operating cash flow has remained positive across periods, while free cash flow turned solidly positive in 2024 and strengthened further in TTM. This provides an internal funding base for operations and investment over the medium term.

Bears Say

High Leverage

Debt relative to equity was very high in 2025 and TTM, leaving limited balance-sheet flexibility. With equity small versus assets, weaker earnings or higher financing costs could magnify solvency pressure and constrain investment or capital allocation.

Limited Deleveraging Capacity

TTM free cash flow remains relatively low compared with reported earnings, and operating cash flow covers only a modest portion of total debt. This limits deleveraging capacity and leaves the company more sensitive to refinancing needs over the medium term.

Thin And Incompletely Recovered Margins

Net margin remains thin, and margins have not fully recovered to stronger 2024 levels. The incomplete recovery suggests profitability can remain exposed to cost and pricing pressure, limiting how much revenue growth translates into durable bottom-line expansion.

017810 FAQ

What was Pulmuone Corporate’s price range in the past 12 months?

Pulmuone Corporate lowest stock price was $8000.00 and its highest was $14120.00 in the past 12 months.

What is Pulmuone Corporate’s market cap?

Pulmuone Corporate’s market cap is ₩296.62B.

When is Pulmuone Corporate’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Pulmuone Corporate’s earnings last quarter?

Pulmuone Corporate released its earnings results on Aug 14, 2026. The company reported $214.631 earnings per share for the quarter.

Is Pulmuone Corporate overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Pulmuone Corporate pay dividends?

Pulmuone Corporate pays a ― dividend of $102 which represents an annual dividend yield of 1.27%. See more information on Pulmuone Corporate dividends here

What is Pulmuone Corporate’s EPS estimate?

Pulmuone Corporate’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pulmuone Corporate have?

Pulmuone Corporate has 38,120,540 shares outstanding.

What happened to Pulmuone Corporate’s price movement after its last earnings report?

Pulmuone Corporate reported an EPS of $214.631 in its last earnings report. Following the earnings report the stock price went up 6.87%.

Which hedge fund is a major shareholder of Pulmuone Corporate?

Currently, no hedge funds are holding shares in KR:017810

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description